Platelet-to-lymphocyte Ratio As a Prognostic Predictor of Mortality for Sepsis: Interaction Effect with Disease Severity-a Retrospective Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2019 Feb 21

PMID 30782690

Citations 65

Authors

Yanfei Shen

Xinmei Huang

Weimin Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: The role of platelet-to-lymphocyte ratio (PLR) as an indicator of inflammation has been the focus of research recently. We aimed to investigate the value of PLR for sepsis.

Design: A retrospective cohort study.

Setting And Participants: Data were extracted from the Multiparameter Intelligent Monitoring in Intensive Care III database. Data on 5537 sepsis patients were analysed.

Methods: Logistic regression was used to explore the association between PLR and hospital mortality. Subgroup analyses were performed based on vasopressor use, acute kidney injury (AKI) and a Sequential Organ Failure Assessment (SOFA) score >10.

Results: In the logistic model with linear spline function, a PLR >200 was significantly (OR 1.0002; 95% CI 1.0001 to 1.0004) associated with mortality; the association was for PLRs ≤200 (OR 0.997; 95% CI 1.19 to 1.67). In the logistic model using the PLR as a design variable, only high PLRs were significantly associated with mortality (OR 1.29; 95% CI 1.09 to 1.53); the association with low PLRs was (OR 1.15; 95% CI 0.96 to 1.38). In the subgroups with vasopressor use, AKI and a SOFA score >10, the association between high PLR and mortality was ; this remained significant in the subgroups without vasopressor use (OR 1.39; 95% CI 1.08 to 1.77) and AKI (OR 1.54; 95% CI 1.20 to 1.99) and with a SOFA score ≤10 (OR 1.51; 95% CI 1.17 to 1.94).

Conclusions: High PLRs at admission were associated with an increased risk of mortality. In patients with vasopressor use, AKI or a SOFA score >10, this association was

Citing Articles

The relationship between hemoglobin, albumin, lymphocyte, and platelet (HALP) score and 28-day mortality in patients with sepsis: a retrospective analysis of the MIMIC-IV database.

Li H, Zhou Y, Zhang X, Yao R, Li N BMC Infect Dis. 2025; 25(1):333.

PMID: 40065235 PMC: 11892195. DOI: 10.1186/s12879-025-10739-3.

Higher neutrophil-lymphocyte ratio predicts poor response to repetetive transcranial magnetic stimulation(rTMS) in treatment resistant depression.

Koparal B, Temizkan H, Aksu M, Karadag R Eur Arch Psychiatry Clin Neurosci. 2025; .

PMID: 40042668 DOI: 10.1007/s00406-025-01977-2.

The Effect of Laboratory Parameters on the Hospital Stay and Mortality in Pediatric Patients Who Underwent Lobectomy and Pneumonectomy.

Ulusan A, Danaci H, Elma B, Sanli M, Isik A Medicina (Kaunas). 2025; 61(1).

PMID: 39859008 PMC: 11766857. DOI: 10.3390/medicina61010026.

Phenotypic age mediates the associations between platelet-to-lymphocyte ratio and all-cause and cause-specific mortality: A prospective cohort study.

Li X, Wang J, Zhang M, Li Y, Li X, Zhang J Heliyon. 2025; 11(1):e41506.

PMID: 39831170 PMC: 11742625. DOI: 10.1016/j.heliyon.2024.e41506.

A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units.

H B S, Fernandes A, Dsouza S, B P, Rao P, Shenoy M S F1000Res. 2024; 13:997.

PMID: 39649834 PMC: 11621608. DOI: 10.12688/f1000research.154812.2.

References

Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H . Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013; 8(7):e67688. PMC: 3699634. DOI: 10.1371/journal.pone.0067688. View

Toda M, Tsukioka T, Izumi N, Komatsu H, Okada S, Hara K . Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy. Thorac Cancer. 2017; 9(1):112-119. PMC: 5754286. DOI: 10.1111/1759-7714.12547. View

Mao Y, Fu Y, Gao Y, Yang A, Zhang Q . Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer. Eur Arch Otorhinolaryngol. 2017; 275(2):553-559. DOI: 10.1007/s00405-017-4849-4. View

Kellum J, Lameire N . Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013; 17(1):204. PMC: 4057151. DOI: 10.1186/cc11454. View

Vincent J . Emerging therapies for the treatment of sepsis. Curr Opin Anaesthesiol. 2015; 28(4):411-6. DOI: 10.1097/ACO.0000000000000210. View

Nunez J, Minana G, Bodi V, Nunez E, Sanchis J, Husser O . Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011; 18(21):3226-33. DOI: 10.2174/092986711796391633. View

Pierrakos C, Vincent J . Sepsis biomarkers: a review. Crit Care. 2010; 14(1):R15. PMC: 2875530. DOI: 10.1186/cc8872. View

Zhang Z, Lu B, Ni H, Sheng X, Jin N . Prediction of pulmonary edema by plasma protein levels in patients with sepsis. J Crit Care. 2012; 27(6):623-9. DOI: 10.1016/j.jcrc.2012.08.007. View

Wang Y, Zhi Q, Wang X, Yue D, Li K, Jiang R . Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer. Oncol Lett. 2017; 14(4):4331-4338. PMC: 5594242. DOI: 10.3892/ol.2017.6660. View

10.

Manzoli T, Delgado A, Troster E, Brunow de Carvalho W, Antunes A, Marques D . Lymphocyte count as a sign of immunoparalysis and its correlation with nutritional status in pediatric intensive care patients with sepsis: A pilot study. Clinics (Sao Paulo). 2016; 71(11):644-649. PMC: 5108166. DOI: 10.6061/clinics/2016(11)05. View

11.

Cohen J, Vincent J, Adhikari N, Machado F, Angus D, Calandra T . Sepsis: a roadmap for future research. Lancet Infect Dis. 2015; 15(5):581-614. DOI: 10.1016/S1473-3099(15)70112-X. View

12.

Felmet K, Hall M, Clark R, Jaffe R, Carcillo J . Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol. 2005; 174(6):3765-72. DOI: 10.4049/jimmunol.174.6.3765. View

13.

Akbas E, Hamur H, Demirtas L, Bakirci E, Ozcicek A, Ozcicek F . Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2014; 6:55. PMC: 4018267. DOI: 10.1186/1758-5996-6-55. View

14.

Zavada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G . A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010; 25(12):3911-8. DOI: 10.1093/ndt/gfp766. View

15.

Azab B, Shah N, Akerman M, McGinn Jr J . Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34(3):326-34. DOI: 10.1007/s11239-012-0718-6. View

16.

Nording H, Seizer P, Langer H . Platelets in inflammation and atherogenesis. Front Immunol. 2015; 6:98. PMC: 4351644. DOI: 10.3389/fimmu.2015.00098. View

17.

Mertoglu C, Gunay M . Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2016; 11 Suppl 1:S127-S131. DOI: 10.1016/j.dsx.2016.12.021. View

18.

Akboga M, Canpolat U, Yayla C, Ozcan F, Ozeke O, Topaloglu S . Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease. Angiology. 2015; 67(1):89-95. DOI: 10.1177/0003319715583186. View

19.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

20.

Claushuis T, van Vught L, Scicluna B, Wiewel M, Klein Klouwenberg P, Hoogendijk A . Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. 2016; 127(24):3062-72. DOI: 10.1182/blood-2015-11-680744. View